Clinical Utility of Viral Load in the Management of Cytomegalovirus Infection in Solid Organ Transplant Patients in Kuwait

Transplantation Proceedings

Volumn 47, Issue 6, 2015, Pages 1802-1807

  Madi, N ^a   Al Qaser, M ^a   Edan, R ^a   Al Nakib, W ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; DACLIZUMAB; GANCICLOVIR; MYCOPHENOLATE MOFETIL; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VIRUS DNA;

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; BLOOD SAMPLING; CYTOMEGALOVIRUS INFECTION; FEMALE; FEVER; FOLLOW UP; GRAFT REJECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; INFECTION PREVENTION; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; KUWAIT; LEUKOPENIA; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT DURATION; VIRUS DETECTION; VIRUS LOAD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MANAGEMENT; GENETICS; INCIDENCE; MIDDLE AGED; UTILIZATION; VIROLOGY;

ADULT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MANAGEMENT; DNA, VIRAL; FEMALE; HUMANS; INCIDENCE; KUWAIT; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; REAL-TIME POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 84939424047     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2015.05.007     Document Type: Article

References (25)

1. R.R. Razonable, and R.T. Hayden Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation Clin Microbiol Rev 26 2013 703 727
2. R.H. Rubin Preemptive therapy in immunocompromised hosts N Engl J Med 324 1991 1057 1059
3. M.E. Falagas, D.R. Snydman, J. Griffith, B.G. Werner Boston Center for Liver Transplantation CMVIG Study Group Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Clin Infect Dis 23 1996 468 474
4. C.S. Kraft, W.S. Armstrong, and A.M. Caliendo Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective Clin Infect Dis 54 2012 1793 1797
5. C. Martín-Gandul, P. Pérez-Romero, M. Sánchez, G. Bernal, G. Suárez, M. Sobrino, and et al. Determination, validation and standardization of a CMV DNA cutoff value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection J Clin Virol 56 2013 13 18
6. C. Gimeno, C. Solano, J.C. Latorre, J.C. Hernández-Boluda, M.A. Clari, M.J. Remigia, and et al. Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients J Clin Microbiol 46 2008 3311 3318
7. S.-M. Choi, D.-G. Lee, J. Lim, S.H. Park, J.-H. Choi, J.-H. Yoo, and et al. Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients J Korean Med Sci 24 2009 571 578
8. C.N. Kotton, D. Kumar, A.M. Caliendo, A. Asberg, S. Chou, D.R. Snydman, and et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation Transplantation 89 2010 779 795
9. N. Madi, W. Al-Nakib, A.S. Mustafa, T. Saeed, A. Pacsa, and M.R.N. Nampoory Detection and monitoring of cytomegalovirus infection in renal transplant patients by quantitative real-time PCR Med Princ Pract 16 2007 268 273
10. E. Gault, Y. Michel, A. Dehée, C. Belabani, J.C. Nicolas, and A. Garbarg-Chenon Quantification of human cytomegalovirus DNA by real-time PCR J Clin Microbiol 39 2001 772 775
11. M.M. Abecassis, A.J. Koffron, M. Buckingham, D.B. Kaufman, J.P. Fryer, J. Stuart, and et al. Role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for development of disease and should PCR be used to guide antiviral therapy? Transplant Proc 29 1997 800 801
12. J.S. Kalpoe, A.C.M. Kroes, M.D. de Jong, J. Schinkel, C.S. de Brouwer, M.F.C. Beersma, and et al. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection J Clin Microbiol 42 2004 1498 1504
13. E. Hryniewiecka, D. Sołdacki, and L. Pączek Cytomegaloviral infection in solid organ transplant recipients: preliminary report of one transplant center experience Transplant Proc 46 2014 2572 2575
14. L. Linares, G. Sanclemente, C. Cervera, I. Hoyo, F. Cofán, M.J. Ricart, and et al. Influence of cytomegalovirus disease in outcome of solid organ transplant patients Transplant Proc 43 2011 2145 2148
15. A. Roman, N. Manito, J.M. Campistol, V. Cuervas-Mons, L. Almenar, M. Arias, and et al. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients Transplant Rev (Orlando) 28 2014 84 91
16. J.G. Katsolis, W. Bosch, M.G. Heckman, N.N. Diehl, J.A. Shalev, S. Pungpapong, and et al. Evaluation of risk factors for cytomegalovirus infection and disease occurring within 1 year of liver transplantation in high-risk patients Transpl Infect Dis 15 2013 171 180
17. M. Stern, H. Hirsch, A. Cusini, C. van Delden, O. Manuel, P. Meylan, and et al. Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment Transplantation 98 2014 1013 1018
18. R.R. Razonable, and C.V. Paya Infections and allograft rejection - intertwined complications of organ transplantation Swiss Med Wkly 135 2005 571 573
19. H. Piiparinen, K. Höckerstedt, M. Lappalainen, J. Suni, and I. Lautenschlager Monitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplant patients J Clin Microbiol 40 2002 2945 2952
20. A. Humar, D. Gregson, A.M. Caliendo, A. McGeer, G. Malkan, M. Krajden, and et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients Transplantation 68 1999 1305 1311
21. H. Piiparinen, K. Höckerstedt, C. Grönhagen-Riska, and I. Lautenschlager Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and Taqman assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients J Clin Virol 30 2004 258 266
22. P. Martín-Dávila, J. Fortún, C. Gutiérrez, P. Martí-Belda, A. Candelas, A. Honrubia, and et al. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cutoff value J Clin Virol 33 2005 138 144
23. A. Humar, D. Kumar, G. Boivin, and A.M. Caliendo Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease J Infect Dis 186 2002 829 833
24. P. Ramanan, and R.R. Razonable Cytomegalovirus infections in solid organ transplantation: a review Infect Chemother 45 2013 260 271
25. R.R. Razonable, A. Åsberg, H. Rollag, J. Duncan, D. Boisvert, J.D. Yao, and et al. Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients Clin Infect Dis 56 2013 1546 1553